9 results match your criteria: "MGH and Harvard Medical School (HMS)[Affiliation]"

Background & Aims: Identifying fibrosis in non-alcoholic fatty liver disease (NAFLD) is essential to predict liver-related outcomes and guide treatment decisions. A protein-based signature of fibrosis could serve as a valuable, non-invasive diagnostic tool. This study sought to identify circulating proteins associated with fibrosis in NAFLD.

View Article and Find Full Text PDF

Immune checkpoint blockers (ICBs) have failed in all phase III glioblastoma (GBM) trials. Here, we show that regulatory T (Treg) cells play a key role in GBM resistance to ICBs in experimental gliomas. Targeting glucocorticoid-induced TNFR-related receptor (GITR) in Treg cells using an agonistic antibody (αGITR) promotes CD4 Treg cell differentiation into CD4 effector T cells, alleviates Treg cell-mediated suppression of anti-tumor immune response, and induces potent anti-tumor effector cells in GBM.

View Article and Find Full Text PDF

Progression of Metastasis through Lymphatic System.

Cells

March 2021

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH) Cancer Center, MGH and Harvard Medical School (HMS), Boston, MA 02114, USA.

Lymph nodes are the most common sites of metastasis in cancer patients. Nodal disease status provides great prognostic power, but how lymph node metastases should be treated is under debate. Thus, it is important to understand the mechanisms by which lymph node metastases progress and how they can be targeted to provide therapeutic benefits.

View Article and Find Full Text PDF

Fate Mapping of Cancer Cells in Metastatic Lymph Nodes Using Photoconvertible Proteins.

Methods Mol Biol

April 2021

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH) Research Institute, MGH and Harvard Medical School (HMS), Boston, MA, USA.

The lymph node microenvironment is extremely dynamic and responds to immune stimuli in the host by reprogramming immune, stromal, and endothelial cells. In normal physiological conditions, the lymph node will initiate an appropriate immune response to clear external threats that the host may experience. However, in metastatic disease, cancer cells often colonize local lymph nodes, disrupt immune function, and even leave the lymph node to create additional metastases.

View Article and Find Full Text PDF

There are currently no proven or approved treatments for coronavirus disease 2019 (COVID-19). Early anecdotal reports and limited in vitro data led to the significant uptake of hydroxychloroquine (HCQ), and to lesser extent chloroquine (CQ), for many patients with this disease. As an increasing number of patients with COVID-19 are treated with these agents and more evidence accumulates, there continues to be no high-quality clinical data showing a clear benefit of these agents for this disease.

View Article and Find Full Text PDF

Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice.

Science

March 2018

Edwin L. Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital (MGH) Cancer Center, MGH and Harvard Medical School (HMS), Boston, MA 02114, USA.

Lymph node metastases in cancer patients are associated with tumor aggressiveness, poorer prognoses, and the recommendation for systemic therapy. Whether cancer cells in lymph nodes can seed distant metastases has been a subject of considerable debate. We studied mice implanted with cancer cells (mammary carcinoma, squamous cell carcinoma, or melanoma) expressing the photoconvertible protein Dendra2.

View Article and Find Full Text PDF

Although targeted therapies are often effective systemically, they fail to adequately control brain metastases. In preclinical models of breast cancer that faithfully recapitulate the disparate clinical responses in these microenvironments, we observed that brain metastases evade phosphatidylinositide 3-kinase (PI3K) inhibition despite drug accumulation in the brain lesions. In comparison to extracranial disease, we observed increased HER3 expression and phosphorylation in brain lesions.

View Article and Find Full Text PDF

The Commonality of Loss Aversion across Procedures and Stimuli.

PLoS One

June 2016

Warren Wright Adolescent Center, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America; Laboratory of Neuroimaging and Genetics, Department of Psychiatry, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), Boston, MA, United States of America; Mood and Motor Control Laboratory, MGH and HMS, Boston, MA, United States of America; Massachusetts General Hospital and Northwestern University Phenotype Genotype Project in Addiction and Mood Disorders.

Individuals tend to give losses approximately 2-fold the weight that they give gains. Such approximations of loss aversion (LA) are almost always measured in the stimulus domain of money, rather than objects or pictures. Recent work on preference-based decision-making with a schedule-less keypress task (relative preference theory, RPT) has provided a mathematical formulation for LA similar to that in prospect theory (PT), but makes no parametric assumptions in the computation of LA, uses a variable tied to communication theory (i.

View Article and Find Full Text PDF

Molecular imaging of macrophage enzyme activity in cardiac inflammation.

Curr Cardiovasc Imaging Rep

April 2014

Center for Systems Biology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS), 185 Cambridge Street, Boston, MA 02114 ; Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114.

Molecular imaging is highly advantageous as various insidious inflammatory events can be imaged in a serial and quantitative fashion. Combined with the conventional imaging modalities like computed tomography (CT), magnetic resonance (MR) and nuclear imaging, it helps us resolve the extent of ongoing pathology, quantify inflammation and predict outcome. Macrophages are increasingly gaining importance as an imaging biomarker in inflammatory cardiovascular diseases.

View Article and Find Full Text PDF